Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.04
+0.04 (0.36%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $7.86 billion as of April 25, 2025. Its market cap has decreased by -12.96% in one year.
Market Cap
7.86B
Enterprise Value
2.81B
1-Year Change
-12.96%
Ranking
Category
Stock Price
$11.04
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $7.86B, an increase of 1,372.91%. That is a compound annual growth rate of 84.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 7.86B | -8.77% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 769.77B |
| UnitedHealth Group | 386.89B |
| Johnson & Johnson | 371.50B |
| AbbVie | 318.91B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.29B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |